Ameriprise
TENX icon

Ameriprise’s Tenax Therapeutics TENX Stock Holding History

Ameriprise’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.47M Buy
+279,537
New +$3.78M ﹤0.01% 2508
2021
Q3 		– Sell
-19
Closed -$62K – 3960
2021
Q2 		$62K Hold
19
– – ﹤0.01% 3848
2021
Q1 		$57K Hold
19
– – ﹤0.01% 3797
2020
Q4 		$56K Hold
19
– – ﹤0.01% 3719
2020
Q3 		$46K Hold
19
– – ﹤0.01% 3678
2020
Q2 		$27K Buy
+19
New +$27.9K ﹤0.01% 3637

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return